Moderna (NASDAQ:MRNA) Price Target Lowered to $26.00 at JPMorgan Chase & Co.
Moderna (NASDAQ:MRNA – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $33.00 to $26.00 in a report issued on Thursday,Benzinga reports. The firm currently has an underweight rating on the stock. Several other analysts have also recently issued reports on the stock. Evercore ISI lowered their target price on shares […]
Moderna (NASDAQ:MRNA – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $33.00 to $26.00 in a report issued on Thursday,Benzinga reports. The firm currently has an underweight rating on the stock. Several other analysts have also recently issued reports on the stock. Evercore ISI lowered their target price on shares […]
